ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q2SCImago #2,948Hybrid

Clinical and Experimental Allergy

Acronym:cea
•
Abbreviation (ISO):CLIN EXP ALLERGY
•
Identifier (ISSN):0954-7894(Print)/1365-2222(Online)
•
Publisher:Wiley-Blackwell Publishing Ltd
Clarivate IF (2026)
5↓ -0.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Clinical and Experimental Allergy

WoS Q1
24795.1620184.7420194.2220205.0220215.420226.120236.320245.2202552026
Annual Impact Factor Metric
Current (2026):5
Scopus SJR & RankScopus Q2
1.35
#2,948

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
182

182 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate6.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
107articles/year
57.8% Gold OA•76% Original Research

Aims & Scope

Clinical & Experimental Allergy strikes an excellent balance between clinical and scientific articles and carries regular reviews and editorials written by leading authorities in their field. In response to the increasing number of quality submissions, since 1996 the journals size has increased by over 30%. Clinical & Experimental Allergy is essential reading for allergy practitioners and research scientists with an interest in allergic diseases and mechanisms. Truly international in appeal, Clinical & Experimental Allergy publishes clinical and experimental observations in disease in all fields of medicine in which allergic hypersensitivity plays a part.

Topics Covered (Recognized by AI)
Medicine99%Biology83.9%Immunology80.1%Internal medicine65.2%Genetics57.3%Allergy47.7%Chemistry42.6%Asthma39.8%Pathology37.6%Biochemistry36.8%Antibody32.9%Immunoglobulin E29%Psychology23.3%Allergen21.3%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ALLERGY

Q1
Rank10/40
IndexSCIE
JCRSCIE2026

IMMUNOLOGY

Q2
Rank52/183
IndexSCIE
JCISCIE2026

ALLERGY

Q2
Rank14/40
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q2
Rank64/183
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5
Articles / Year238
Total Citations74
2025
IF5.2
Articles / Year260
Total Citations542
2024
IF6.3
Articles / Year186
Total Citations965
2023
IF6.1
Articles / Year181
Total Citations1,166
2022
IF5.401
Articles / Year198
Total Citations2,026

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,948Scopus Q2SCImago Profile
Scopus Coverage:1971-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicine
Scopus Citation Rank (SJR)Q2
1.35

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
2.72

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,504 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,386
3-Year Documents503
Citable Documents217

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate49.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

ImmunologyQ2
Immunology and AllergyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 6.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区ALLERGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Clinical and Experimental Allergy (acronym: cea, abbr: CLIN EXP ALLERGY, ISSN: 0954-7894) is a peer-reviewed international scholarly journal in the field of Medicine, published by Wiley-Blackwell Publishing Ltd in England since 1989. The periodical holds a Journal Impact Factor (JIF) of 5.00, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.350 (Q2), an H-index of 182.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 107 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,504 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Wiley-Blackwell Publishing Ltd
Publication Language
English
Frequency
Monthly
Founding Year
1989
Indexing & Databases
SCIEScopusPubMed
Editorial Address
WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 38c4de29-93d0-427a-b30e-7bd36edd3bba
Database Updated: 2026-10-01